Synthesizing and investigating novel synthetic cannabidiol congeners for enhanced clinical utility
The Invention:
Developed an innovative method to convert caraway-derived (+)-carvone (1, $0.15/g) into (–)- isopiperitenol (3, $1000/g) – a critical intermediate that was previously employed in the synthesis (+)-ent-CBD [(+)-5, Scheme 1]. Of note, this four step process (1 to 3) can be performed on multi-gram scale and relies on the one-pot...
Published: 1/13/2025
|
Inventor(s): Rochelle Hines, Dustin Hines, William Maio
Keywords(s): Chemistry, Life Science, Life Science - Health, Therapeutics & Drug Delivery, Therapeutics & Drug Delivery - Therapeutic
Category(s): All
|